Publications by authors named "Aurelio Castrellon"

Claim this Profile
T
The Role of CD4/6 Inhibitors in Breast Cancer Treatment.
Luv Purohit, Can Jones, Teresita Gonzalez, Aurelio Castrellon, Atif Hussein

Int J Mol Sci· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using cfRNA as a tool to evaluate clinical treatment outcomes in patients with metastatic lung cancers and other tumors.
Luis E Raez, Kathleen Danenberg, Daniel Sumarriva, Joshua Usher, Jacob Sands, Aurelio Castrellon

Cancer Drug Resist· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression-free Survival Outcome Is Independent of Objective Response in Patients With Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer Treated With Palbociclib Plus Letrozole Compared With Letrozole: Analysis From PALOMA-2.
Hope S Rugo, Richard S Finn, Karen Gelmon, Anil A Joy, Nadia Harbeck, Aurelio Castrellon

Clin Breast Cancer· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Open Label Study of Everolimus in Combination With Endocrine Therapy in Resistant Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer.
Denise A Yardley, William Liggett, Mark Mainwaring, Aurelio Castrellon, Laura Blakely

Clin Breast Cancer· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.
Karen A Gelmon, Massimo Cristofanilli, Hope S Rugo, Angela M DeMichele, Anil A Joy, Aurelio Castrellon

Breast J· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-09).
Sara Hurvitz, Rashi Singh, Brad Adams, Julie A Taguchi, David Chan, Aurelio Castrellon

Ther Adv Med Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of weekly paclitaxel plus carboplatin followed by anthracycline chemotherapy on the neoadjuvant treatment of patients with triple-negative breast cancer.
Aurelio B Castrellon, Michel Velez, Steven M Nguyen, Marcelo Blaya, Sandra Barnick

Hematol Oncol Stem Cell Ther· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic Radiosurgery and Ipilimumab Versus Stereotactic Radiosurgery Alone in Melanoma Brain Metastases.
Steven M Nguyen, Aurelio Castrellon, Oliver Vaidis, Andrew E Johnson

Cureus· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impressive Response to Concomitant Platinum-based Chemotherapy and Yttrium-90 in a Patient with Heavily Pretreated Triple-negative Breast Cancer Widely Metastasized to the Liver.
Aurelio Castrellon, Steven M Nguyen, Federico Bengoa, Ana Botero, Luis E Raez

Cureus· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Carboplatin in the Neoadjuvant Chemotherapy Treatment of Triple Negative Breast Cancer.
Aurelio Bartolome Castrellon, Ihor Pidhorecky, Vicente Valero, Luis Estuardo Raez

Oncol Rev· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Strategies to Improve the Endocrine Therapy of Breast Cancer.
Aurelio Bartolome Castrellon

Oncol Rev· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer.
Christopher Lobo, Gilberto Lopes, Odalys Baez, Aurelio Castrellon, Annapoorna Ferrell

Breast Cancer Res Treat· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nasopharyngeal carcinoma: alternative treatment options after disease progression.
Belisario A Arango, Aurelio B Castrellon, Cesar A Perez, Luis E Raez, Edgardo S Santos

Expert Rev Anticancer Ther· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lapatinib plus capecitabine resolved human epidermal growth factor receptor 2-positive brain metastases.
Stefan Glück, Aurelio Castrellon

Am J Ther· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crohn's disease complicated by primary gastrointestinal Hodgkin's lymphoma presenting with small bowel perforation.
Aurelio Castrellon, Paul Andrew Feldman, Miguel Suarez, Seth Spector, Lucy Chua

J Gastrointestin Liver Dis· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line therapy for non-small-cell lung cancer.
Belisario A Arango, Aurelio B Castrellon, Edgardo S Santos, Luis E Raez

Clin Lung Cancer· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controversies in the management of stage IIIA non-small-cell lung cancer.
Edgardo S Santos, Aurelio Castrellon, Marcelo Blaya, Luis E Raez

Expert Rev Anticancer Ther· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant therapy for HER2 positive breast cancer: are anthracyclines still necessary?
Aurelio B Castrellon, Stefan Glück

Clin Adv Hematol Oncol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pericardial effusion in a patient with acquired factor V inhibitor.
Francisco Yuri Bulcão Macedo, Samora Coterell, Darren Sidney, Emanuelle Bellaguarda, Ricardo Franco, Aurelio Castrellon

Ann Hematol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemoprevention of breast cancer.
Aurelio B Castrellon, Stefan Glück

Expert Rev Anticancer Ther· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digoxin use is associated with increased platelet and endothelial cell activation in patients with nonvalvular atrial fibrillation.
Julio A Chirinos, Aurelio Castrellon, Juan Pablo Zambrano, Joaquin J Jimenez, Wenche Jy

Heart Rhythm· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis